987-P: Comparative Cardiovascular (CV) Effectiveness of SGLT2 Inhibitors (SGLT2i) and GLP-1 Receptor Agonists (GLP-1 RA) in Patients with Type 2 Diabetes Mellitus (T2DM): A Large National Database Study

Volume: 70
Published: Jun 1, 2021
Abstract
Introduction: SGLT2i (S) and GLP-1 RA (G) are both known to have well established cardio protective effects in patients with T2DM. However, the comparative CV efficacy of these drugs is not well known. null Methods: We used a national hospital-based database (Explorys Inc, IBM) to compare the CV outcomes (CVO) among patients receiving S or G. T2DM patients were divided in 3 groups- combination therapy (G+S), only G and only S. First, CVO were...
Paper Details
Title
987-P: Comparative Cardiovascular (CV) Effectiveness of SGLT2 Inhibitors (SGLT2i) and GLP-1 Receptor Agonists (GLP-1 RA) in Patients with Type 2 Diabetes Mellitus (T2DM): A Large National Database Study
Published Date
Jun 1, 2021
Journal
Volume
70
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.